Japan AGM Voting Results & Director Approval
Annual meeting voting results, director support and shareholder dissent.
Data through · Updated with new filings
0
board nominees with under 80% support at 2026 meetings
The lowest was Wakamoto Pharmaceutical's nominee at 85.71%.
1 row matches “4512” · Clear · Go to Wakamoto Pharmaceutical (4512) →
Lowest director approval
11 meeting · 5 board nominees, each meeting's lowest approval first
The line marks 80% approval.
| Director | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| 五十嵐 新+4 other nominees, 85.75%–98.93%Wakamoto Pharmaceutical4512 · わかもと製薬 | Election of 4 directors (excluding audit committee directors)Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件 | 85.71%Votes cast: 86.04% · For 257,351 / Against 41,770 / Abstain 0 | Approved | Filed — filing S100YKND |
Rejected proposals
1| Company | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| Wakamoto Pharmaceutical4512 · わかもと製薬 | Partial amendment of the articles of incorporation regarding formulation of a medium-term management plan for enhancing shareholder valueMachine translatedOriginal (Japanese)株主価値向上に向けた中期経営計画策定に関する定款一部変更の件 | 17.08%Votes cast: — · For 51,286 / Against 247,775 / Abstain — | Rejected | Filed — filing S100YKND |
Shareholder proposals ≥ 20%
0No stored data for this selection.
Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).
† Percentage of votes cast; company did not state a ratio.
† Company-stated ratio differs from tallied votes.
Related tools
Tender offers
Tender offer prices, windows, conditions and disclosed outcomes.
Activist & 5% stakes
Disclosed stakes above 5%, with activist groups and ownership changes.